Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The problems of antibiotic resistance in cystic fibrosis and solutions.

Expert review of respiratory medicine - 1 Feb 2015

López-Causapé Carla, Rojo-Molinero Estrella, Macià María D, Oliver Antonio

Abstract excerpt

Chronic respiratory infection is the main cause of morbidity and mortality in cystic fibrosis (CF) patients. One of the hallmarks of these infections, led by the opportunistic pathogen Pseudomonas aeruginosa, is their long-term (lifelong) persistence despite intensive antimicrobial therapy. Antimicrobial resistance in CF is indeed a multifactorial problem, which includes physiological changes, represented by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biofilms
Share to Chronic Disease
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Bacterial

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Share to Respiratory Tract Infections

Source

Identifiers

PMID: 25541089
DOI: 10.1586/17476348.2015.995640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The problems of antibiotic resistance in cystic fibrosis and solutions.PMID 25541089Read ↗

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking TherapiesSemantic proximity Read ↗

New Treatments for Emerging Cystic Fibrosis Pathogens other than PseudomonasSemantic proximity Read ↗

Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic FibrosisSemantic proximity Read ↗

Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.Semantic proximity Read ↗

Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.Semantic proximity Read ↗

Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.Semantic proximity Read ↗

Pseudomonas aeruginosa in cystic fibrosis: Pathogenesis and new treatmentsSemantic proximity Read ↗

Clinically-relevant altered antibiotic responses and mechanisms of β-lactam sensitization of MRSA in cystic fibrosis artificial sputumSemantic proximity Read ↗

Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workersSemantic proximity Read ↗

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosaSemantic proximity Read ↗

Hypermutator <i>Pseudomonas aeruginosa</i> exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patientsSemantic proximity Read ↗

Update on key emerging challenges in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.